Abstract
BackgroundAdoptive cell therapy with tumor-infiltrating lymphocytes (TIL) can mediate effective responses in solid tumors.1–3 However, the use of live feeder cells during TIL manufacture may limit the scalability of TIL...
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have